COHERUS BIOSCIENCES INC's ticker is CHRS and the CUSIP is 19249H103. A total of 159 filers reported holding COHERUS BIOSCIENCES INC in Q4 2023. The put-call ratio across all filers is 0.66 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $757,372 | -12.4% | 202,506 | 0.0% | 0.02% | -10.0% |
| Q2 2023 | $864,701 | -37.6% | 202,506 | 0.0% | 0.02% | -51.2% |
| Q1 2023 | $1,385,141 | -13.6% | 202,506 | 0.0% | 0.04% | -8.9% |
| Q4 2022 | $1,603,848 | -17.6% | 202,506 | -0.0% | 0.04% | -21.1% |
| Q3 2022 | $1,946,000 | +59.4% | 202,536 | +132.1% | 0.06% | +147.8% |
| Q2 2018 | $1,221,000 | +24.6% | 87,248 | -1.6% | 0.02% | +21.1% |
| Q1 2018 | $980,000 | +15.0% | 88,680 | -8.4% | 0.02% | +26.7% |
| Q4 2017 | $852,000 | -34.9% | 96,784 | -1.3% | 0.02% | -37.5% |
| Q3 2017 | $1,308,000 | -8.8% | 98,012 | -1.9% | 0.02% | -11.1% |
| Q2 2017 | $1,434,000 | -44.8% | 99,950 | -18.7% | 0.03% | -40.0% |
| Q1 2017 | $2,599,000 | -24.8% | 122,894 | +0.1% | 0.04% | -25.0% |
| Q4 2016 | $3,457,000 | +135.5% | 122,798 | +124.0% | 0.06% | +114.3% |
| Q3 2016 | $1,468,000 | – | 54,829 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CM Management, LLC | 1,100,000 | $1,903,000 | 1.75% |
| AlphaCentric Advisors LLC | 1,000,000 | $1,730,000 | 1.27% |
| Tejara Capital Ltd | 1,030,386 | $1,782,568 | 0.65% |
| Rubric Capital Management LP | 10,400,000 | $17,992,000 | 0.47% |
| Birchview Capital, LP | 270,000 | $467,100 | 0.43% |
| TANG CAPITAL MANAGEMENT LLC | 1,050,000 | $1,816,500 | 0.18% |
| Bridge City Capital, LLC | 316,009 | $546,696 | 0.18% |
| Kohlberg Kravis Roberts & Co. L.P. | 3,036,076 | $5,252,413 | 0.16% |
| Tyche Wealth Partners LLC | 215,902 | $373,510 | 0.09% |
| Pennant Investors, LP | 168,100 | $290,813 | 0.08% |